{"id": "1380919458470969350", "creation": 1618071829.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "All Eyes Are on Upcoming Novavax's Phase 3 Study Readout\n\n.@Novavax's #COVID19 #vaccine is arriving later to the #pandemic immunization frenzy than #investors wanted but still capable of being a major player in the global supply.\n\n$NVAX $AZN $CVAC $ALT\n\nhttps://t.co/kFT7gzUI7S", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#PANDEMIC", "#INVESTORS"]}